Reports
Sale
North America Colorectal Cancer Screening Tests Market Size: By Screening Tests: Stool-Based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, Others; By End User: Hospitals, Diagnostic Centres/Laboratories, Others; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
North America Colorectal Cancer Screening Tests Market Outlook
The North America colorectal cancer screening tests market size was valued at USD 5.94 billion in 2023. The market is further projected to grow at a CAGR of 5.6% between 2024 and 2032, reaching a value of USD 9.78 billion by 2032.
Key Takeaways
- The American Cancer Society's estimates for colorectal cancers in the United States of America for 2024 are around 106,590 new cases of colon cancer and 46,220 new cases of rectal cancer.
- As per industry reports, in 2021, approximately 24,800 cases of colorectal cancer had been diagnosed in Canada.
- According to the Canadian Cancer Society, colorectal cancer is the fourth most common cancer in the country.
According to the North America colorectal cancer screening tests market report, a rising number of younger people are being diagnosed with colorectal cancer in North America. Factors contributing to an increase in colorectal cancer are an unhealthy diet, lack of physical activity, and a rise in smoking and alcohol consumption as well as genetics or family history. Symptoms of colorectal cancer include blood in stool, changes in bowel habits, and unexplained weight loss. Canadian provinces conduct routine colorectal cancer screening programs, which aids the market growth.
According to the North America colorectal cancer screening tests market analysis, the fecal immunochemical test (FIT) is an easy-to-use stool test that can also be done at home. It can help patients find colorectal cancer early, as well as precancerous conditions that if untreated might become colorectal cancer. In Canada, Ontario, and British Columbia recommend FIT screening every two years, while people living in Alberta are eligible for annual FIT screening. The U.S. Preventive Services Task Force recommends that adults aged between 45 to 75 be regularly screened for colorectal cancer. The colorectal cancer survival rate is rising in Canada and the United States supported by earlier detection of the cancer through routine examinations and screening and due to advances in treatments.
Market Segmentation
North America Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032 offers a detailed analysis of the market based on the following segments.
Market Breakup by Screening Tests
- Stool-Based Tests
- Fecal Immunochemical Test (FIT)
- Fecal Occult Blood Test (FOBT)
- Stool DNA Test
- Colonoscopy
- CT Colonography (Virtual Colonoscopy)
- Flexible Sigmoidoscopy
- Others
Market Breakup by End User
- Hospitals
- Diagnostic Centres/Laboratories
- Others
Market Breakup by Country
- United States of America
- Canada
Competitive Landscape
The key players in the colorectal cancer screening tests market in North America are producing highly efficient colorectal cancer screening tests.
- Abbott Laboratories
- 3T Medical Complete Systems
- Epigenomics AG
- Exact Sciences Corporation
- Roche Diagnostics Corporation
- Siemens AG
- Sysmex Inostics, Inc.
- EKF Diagnostics Holdings Plc
- Laboratory Corporation of America® Holdings.
- LetsGetChecked Inc
- Others
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Screening Tests |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 Global Colorectal Cancer Screening Tests Market Overview
8.1 Key Industry Highlights
8.2 Global Colorectal Cancer Screening Tests Historical Market (2018-2023)
8.3 Global Colorectal Cancer Screening Tests Market Forecast (2024-2032)
8.4 Global Colorectal Cancer Screening Tests Market Share by Region
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Middle East and Africa
9 North America Colorectal Cancer Screening Tests Market Overview
9.1 Key Industry Highlights
9.2 North America Colorectal Cancer Screening Tests Historical Market (2018-2023)
9.3 North America Colorectal Cancer Screening Tests Market Forecast (2024-2032)
10 North America Colorectal Cancer Screening Tests Market by Screening Tests
10.1 Stool-Based Tests
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.1.3 Breakup by Type
10.1.3.1 Fecal Immunochemical Test (FIT)
10.1.3.2 Fecal Occult Blood Test (FOBT)
10.1.3.3 Stool DNA Test
10.2 Colonoscopy
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 CT Colonography (Virtual Colonoscopy)
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Flexible Sigmoidoscopy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 North America Colorectal Cancer Screening Tests Market by End User
11.1 Hospitals
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Diagnostic Centres/Laboratories
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 Others
12 North America Colorectal Cancer Screening Tests Market by Country
12.1 United States of America
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Canada
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
13 Market Dynamics
13.1 SWOT Analysis
13.1.1 Strengths
13.1.2 Weaknesses
13.1.3 Opportunities
13.1.4 Threats
13.2 Porter’s Five Forces Analysis
13.2.1 Supplier’s Power
13.2.2 Buyer’s Power
13.2.3 Threat of New Entrants
13.2.4 Degree of Rivalry
13.2.5 Threat of Substitutes
13.3 Key Indicators for Demand
13.4 Key Indicators for Price
14 Competitive Landscape
14.1 Market Structure
14.2 Company Profiles
14.2.1 Abbott Laboratories
14.2.1.1 Company Overview
14.2.1.2 Product Portfolio
14.2.1.3 Demographic Reach and Achievements
14.2.1.4 Certifications
14.2.2 3T Medical Complete Systems
14.2.2.1 Company Overview
14.2.2.2 Product Portfolio
14.2.2.3 Demographic Reach and Achievements
14.2.2.4 Certifications
14.2.3 Epigenomics AG
14.2.3.1 Company Overview
14.2.3.2 Product Portfolio
14.2.3.3 Demographic Reach and Achievements
14.2.3.4 Certifications
14.2.4 Exact Sciences Corporation
14.2.4.1 Company Overview
14.2.4.2 Product Portfolio
14.2.4.3 Demographic Reach and Achievements
14.2.4.4 Certifications
14.2.5 Roche Diagnostics Corporation
14.2.5.1 Company Overview
14.2.5.2 Product Portfolio
14.2.5.3 Demographic Reach and Achievements
14.2.5.4 Certifications
14.2.6 Siemens AG
14.2.6.1 Company Overview
14.2.6.2 Product Portfolio
14.2.6.3 Demographic Reach and Achievements
14.2.6.4 Certifications
14.2.7 Sysmex Inostics, Inc.
14.2.7.1 Company Overview
14.2.7.2 Product Portfolio
14.2.7.3 Demographic Reach and Achievements
14.2.7.4 Certifications
14.2.8 EKF Diagnostics Holdings Plc
14.2.8.1 Company Overview
14.2.8.2 Product Portfolio
14.2.8.3 Demographic Reach and Achievements
14.2.8.4 Certifications
14.2.9 Laboratory Corporation of America® Holdings.
14.2.9.1 Company Overview
14.2.9.2 Product Portfolio
14.2.9.3 Demographic Reach and Achievements
14.2.9.4 Certifications
14.2.10 LetsGetChecked Inc
14.2.10.1 Company Overview
14.2.10.2 Product Portfolio
14.2.10.3 Demographic Reach and Achievements
14.2.10.4 Certifications
14.2.11 Others
15 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2018 and 2032
2. North America Colorectal Cancer Screening Tests Market: Key Industry Highlights, 2018 and 2032
3. North America Colorectal Cancer Screening Tests Historical Market: Breakup by Screening Tests (USD Billion), 2018-2023
4. North America Colorectal Cancer Screening Tests Market Forecast: Breakup by Screening Tests (USD Billion), 2024-2032
5. North America Colorectal Cancer Screening Tests Historical Market: Breakup by End User (USD Billion), 2018-2023
6. North America Colorectal Cancer Screening Tests Market Forecast: Breakup by End User (USD Billion), 2024-2032
7. North America Colorectal Cancer Screening Tests Historical Market: Breakup by Country (USD Billion), 2018-2023
8. North America Colorectal Cancer Screening Tests Market Forecast: Breakup by Country (USD Billion), 2024-2032
9. North America Colorectal Cancer Screening Tests Market Structure
Key Questions Answered in the Report
In 2023, the colorectal cancer screening tests market reached an approximate value of USD 5.94 billion.
The market is expected to grow at a CAGR of 5.6% between 2024 and 2032.
The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 9.78 billion by 2032.
A colonoscopy is one of the most sensitive tests available for colon cancer screening. The doctor views the patient’s entire colon and rectum and removes abnormal tissue, such as polyps during the exam.
Stool-based tests look at the stool for possible signs of colorectal cancer or polyps.
The major drivers of the market include rising occurrences of colorectal cancer in young patients, advancement in screening technology, and rising awareness of colorectal cancer.
Key trends aiding market expansion include rising emphasis on colorectal cancer screening, the availability of screening kits, and extensive research to enhance the quality and efficiency of colorectal cancer screening kits.
Major regions in the market are the United States of America and Canada.
The end user of colorectal cancer screening tests are hospitals, diagnostic centres/ laboratories, and others.
Key players in the market are Abbott Laboratories, 3T Medical Complete Systems, Epigenomics AG, Exact Sciences Corporation, Roche Diagnostics Corporation, Siemens AG, Sysmex Inostics, Inc., EKF Diagnostics Holdings Plc, Laboratory Corporation of America® Holdings., and LetsGetChecked Inc, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER